|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:FBXO42-RUNX1 (FusionGDB2 ID:29754) |
Fusion Gene Summary for FBXO42-RUNX1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: FBXO42-RUNX1 | Fusion gene ID: 29754 | Hgene | Tgene | Gene symbol | FBXO42 | RUNX1 | Gene ID | 54455 | 861 |
Gene name | F-box protein 42 | RUNX family transcription factor 1 | |
Synonyms | Fbx42|JFK | AML1|AML1-EVI-1|AMLCR1|CBF2alpha|CBFA2|EVI-1|PEBP2aB|PEBP2alpha | |
Cytomap | 1p36.13 | 21q22.12 | |
Type of gene | protein-coding | protein-coding | |
Description | F-box only protein 42just one F-box and Kelch domain-containing protein | runt-related transcription factor 1AML1-EVI-1 fusion proteinPEA2-alpha BPEBP2-alpha BSL3-3 enhancer factor 1 alpha B subunitSL3/AKV core-binding factor alpha B subunitacute myeloid leukemia 1 proteincore-binding factor, runt domain, alpha subunit 2 | |
Modification date | 20200313 | 20200322 | |
UniProtAcc | Q6P3S6 | Q06455 | |
Ensembl transtripts involved in fusion gene | ENST00000375592, ENST00000478089, | ENST00000344691, ENST00000325074, ENST00000437180, ENST00000300305, ENST00000399240, ENST00000486278, ENST00000494829, ENST00000358356, | |
Fusion gene scores | * DoF score | 11 X 10 X 9=990 | 36 X 59 X 13=27612 |
# samples | 17 | 63 | |
** MAII score | log2(17/990*10)=-2.54189377882927 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(63/27612*10)=-5.45379975055797 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FBXO42 [Title/Abstract] AND RUNX1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FBXO42(16678750)-RUNX1(36171759), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | RUNX1 | GO:0030097 | hemopoiesis | 21873977 |
Tgene | RUNX1 | GO:0045893 | positive regulation of transcription, DNA-templated | 10207087|14970218 |
Tgene | RUNX1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 9199349|10207087|14970218|21873977 |
Fusion gene breakpoints across FBXO42 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across RUNX1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-AC-A2FO-01A | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
ChimerDB4 | BRCA | TCGA-AC-A2FO-01A | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
Top |
Fusion Gene ORF analysis for FBXO42-RUNX1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000375592 | ENST00000344691 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
5UTR-3CDS | ENST00000375592 | ENST00000325074 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
5UTR-3CDS | ENST00000375592 | ENST00000437180 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
5UTR-3CDS | ENST00000375592 | ENST00000300305 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
5UTR-3CDS | ENST00000375592 | ENST00000399240 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
5UTR-intron | ENST00000375592 | ENST00000486278 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
5UTR-intron | ENST00000375592 | ENST00000494829 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
5UTR-intron | ENST00000375592 | ENST00000358356 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-3CDS | ENST00000478089 | ENST00000344691 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-3CDS | ENST00000478089 | ENST00000325074 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-3CDS | ENST00000478089 | ENST00000437180 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-3CDS | ENST00000478089 | ENST00000300305 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-3CDS | ENST00000478089 | ENST00000399240 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-intron | ENST00000478089 | ENST00000486278 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-intron | ENST00000478089 | ENST00000494829 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
intron-intron | ENST00000478089 | ENST00000358356 | FBXO42 | chr1 | 16678750 | - | RUNX1 | chr21 | 36171759 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for FBXO42-RUNX1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for FBXO42-RUNX1 |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FBXO42 | RUNX1 |
FUNCTION: Substrate-recognition component of some SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Specifically recognizes p53/TP53, promoting its ubiquitination and degradation. {ECO:0000269|PubMed:19509332}. | FUNCTION: Transcriptional corepressor which facilitates transcriptional repression via its association with DNA-binding transcription factors and recruitment of other corepressors and histone-modifying enzymes (PubMed:12559562, PubMed:15203199, PubMed:10688654). Can repress the expression of MMP7 in a ZBTB33-dependent manner (PubMed:23251453). Can repress transactivation mediated by TCF12 (PubMed:16803958). Acts as a negative regulator of adipogenesis (By similarity). The AML1-MTG8/ETO fusion protein frequently found in leukemic cells is involved in leukemogenesis and contributes to hematopoietic stem/progenitor cell self-renewal (PubMed:23812588). {ECO:0000250|UniProtKB:Q61909, ECO:0000269|PubMed:10688654, ECO:0000269|PubMed:10973986, ECO:0000269|PubMed:16803958, ECO:0000269|PubMed:23251453, ECO:0000269|PubMed:23812588, ECO:0000303|PubMed:12559562, ECO:0000303|PubMed:15203199}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for FBXO42-RUNX1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for FBXO42-RUNX1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FBXO42-RUNX1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FBXO42-RUNX1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | RUNX1 | C1832388 | Platelet Disorder, Familial, with Associated Myeloid Malignancy | 11 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | RUNX1 | C0023467 | Leukemia, Myelocytic, Acute | 4 | CGI;CTD_human;GENOMICS_ENGLAND |
Tgene | RUNX1 | C0026998 | Acute Myeloid Leukemia, M1 | 3 | CTD_human |
Tgene | RUNX1 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 3 | CTD_human |
Tgene | RUNX1 | C0023485 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | CTD_human |
Tgene | RUNX1 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | RUNX1 | C0006413 | Burkitt Lymphoma | 1 | ORPHANET |
Tgene | RUNX1 | C0017636 | Glioblastoma | 1 | CTD_human |
Tgene | RUNX1 | C0023452 | Childhood Acute Lymphoblastic Leukemia | 1 | CTD_human |
Tgene | RUNX1 | C0023453 | L2 Acute Lymphoblastic Leukemia | 1 | CTD_human |
Tgene | RUNX1 | C0023473 | Myeloid Leukemia, Chronic | 1 | ORPHANET |
Tgene | RUNX1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | RUNX1 | C0040034 | Thrombocytopenia | 1 | GENOMICS_ENGLAND |
Tgene | RUNX1 | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
Tgene | RUNX1 | C0349639 | Juvenile Myelomonocytic Leukemia | 1 | CTD_human |
Tgene | RUNX1 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Tgene | RUNX1 | C1292769 | Precursor B-cell lymphoblastic leukemia | 1 | ORPHANET |
Tgene | RUNX1 | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
Tgene | RUNX1 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1 | CTD_human |
Tgene | RUNX1 | C2713368 | Hematopoetic Myelodysplasia | 1 | CTD_human |
Tgene | RUNX1 | C3463824 | MYELODYSPLASTIC SYNDROME | 1 | CTD_human |